Treatment Regimen Videos
Aromatase Inhibitors Treatment
In this video, we cover:
The role of hormone therapy: Why lowering estrogen helps control estrogen receptor (ER)-positive breast cancer..
Your treatment schedule: Taken as a daily pill, often for 5 years or longer.
Managing common side effects: Joint stiffness, hot flashes, bone thinning, and fatigue
In this video, we cover:
The role of combination chemotherapy: How using multiple drugs targets cancer cells in different ways.
Meet the components:
Cyclophosphamide: Damages DNA to stop cancer growth.
Doxorubicin: Interferes with DNA inside rapidly dividing cells.
Vincristine: Blocks cells from dividing.
Prednisone: A steroid that fights cancer and reduces inflammation.
Your treatment schedule: IV chemotherapy given in cycles, plus oral prednisone tablets.
Managing common side effects: Hair loss, fatigue, nausea, lowered blood counts, and infection risk — with supportive medicines like growth factors and anti-nausea drugs.
CHOP Treatment
CARBO + PEMETREXED Treatment
In this video, we cover:
The role of combination chemotherapy: Why pairing two drugs helps target cancer more effectively.
Meet the components:
Carboplatin (Carbo): A platinum-based drug that damages cancer cell DNA.
Pemetrexed: Blocks building blocks cancer cells need to grow and divide.
Your treatment schedule: IV infusions, typically every 3 weeks in repeating cycles.
Managing common side effects: Fatigue, nausea, low blood counts, and infection risk — with vitamin supplementation (folic acid and B12) to reduce side effects.
In this video, we cover:
The role of combination chemotherapy: Why pairing two drugs can be more effective.
Meet the components:
Carboplatin (Carbo): A platinum-based drug that damages the DNA of cancer cells.
Paclitaxel (Taxol): A chemotherapy drug that disrupts the inner structure of cells, stopping them from dividing.
Your treatment schedule: How the drugs are given (typically every 3 weeks, or sometimes weekly) and what to expect during each cycle.
Managing common side effects: Discussion of fatigue, nausea, hair loss, and neuropathy — with tips on how your care team can help.
Carbo–Taxol Treatment
Cisplatin-Gemcitabine Treatment
In this video, we cover:
The role of combination chemotherapy: Why using two drugs together improves effectiveness by attacking cancer cells in different ways.
Meet the components:
Cisplatin: Damages cancer cell DNA, stopping them from dividing and growing.
Gemcitabine: A nucleoside analog that blocks DNA building, preventing cancer cells from repairing themselves.
Managing common side effects: Nausea, vomiting, fatigue, lowered blood counts, risk of infection, and kidney effects.
Dose-Dense AC→T Treatment
This video explains the ddAC→T treatment plan for breast cancer in a simple, clear way. We cover:
What ddAC→T is and why it’s used
Treatment schedule:
AC phase (Adriamycin + Cyclophosphamide) every 2 weeks × 4 cycles
Followed by T phase (Paclitaxel) weekly × 12 or every 2 weeks × 4
Tips for managing side effects and staying safe during treatment
DVRd Treatment
In this video, we cover:
The Power of Four: An introduction to combination therapy and why using four drugs together is so effective against multiple myeloma.
Meet the Components: A clear explanation of each drug in the regimen:
Your Treatment Schedule: A look at what to expect, including the cycles of infusions, injections, and oral medications.
Managing Common Side Effects: A practical discussion of potential side effects, such as fatigue and neuropathy, and how your care team will help manage them.
In this video, we cover:
The role of targeted therapy: How Enhertu combines the precision of antibody therapy with the power of chemotherapy.
Meet the components:
Trastuzumab: Targets HER2, a protein found on some breast, stomach, and lung cancers.
Deruxtecan (chemotherapy payload): Released inside cancer cells to kill them from within.
Your treatment schedule: Given by IV infusion, usually every 3 weeks in cycles.
Managing common side effects: Nausea, fatigue, low blood counts, hair loss, and a serious risk of lung inflammation (interstitial lung disease) — with urgent evaluation if cough or shortness of breath develop.
ENHERTU Treatment
FOLFIRINOX Treatment
This video explains the FOLFIRINOX treatment plan for pancreatic and other gastrointestinal cancers in a clear, simple way. We cover:
What FOLFIRINOX is: a combination of FOLinic acid (leucovorin), Fluorouracil (5-FU), IRINotecan, and OXaliplatin
How it’s given: every 2 weeks in cycles; treatment includes an infusion day followed by a home 5-FU pump for 46 hours
Tips for managing side effects and staying safe during treatment
FOLFOX Treatment
This video explains everything you need to know about FOLFOX chemotherapy in a simple, clear, and patient-friendly way. We cover:
What FOLFOX is and why it’s used to treat colorectal and other cancers
How it’s given — a combination of FOLinic acid (leucovorin), Fluorouracil (5-FU), and OXaliplatin
Treatment schedule — typically given every 2 weeks in cycles
What to expect on infusion day and how the home 5-FU pump works (if used)
Common side effects — neutropenia, nausea, diarrhea, fatigue, neuropathy, and taste changes
Tips for managing side effects and when to call your oncology team immediately
Immunotherapy Treatment
In this video we cover:
How immunotherapy works at the cellular level
Which cancers and patients may benefit
The role of biomarkers and tumor testing in determining eligibility
How the treatment is given (usually by IV infusion)
Common side effects, including immune-related inflammation
Long-term benefits like durable tumor control in some patients
The goal? To harness your own immune system to fight cancer — smarter, longer, and more precisely.
KEYNOTE-522: Triple-Negative Breast Cancer (TNBC) Treatment Protocol
This video explains the KEYNOTE-522 treatment plan for patients with triple-negative breast cancer (TNBC) in a clear and simple way. We cover:
Treatment plan:
Neoadjuvant therapy (before surgery):
Paclitaxel + Carboplatin + Pembrolizumab → weekly for 12 weeks
Followed by AC chemotherapy (Adriamycin + Cyclophosphamide) + Pembrolizumab → every 3 weeks × 4 cycles
Surgery
Adjuvant therapy (after surgery): Pembrolizumab continues for up to 9 cycles
Tips for managing side effects and staying on track during treatment
Pembrolizumab (Keytruda)
This video explains the Pembrolizumab (Keytruda) treatment plan
How it’s given: an IV infusion every 3 or 6 weeks, depending on your treatment plan
Common side effects: fatigue, cough, rash, diarrhea, nausea, and joint pain
Immune-related side effects: Keytruda can affect the lungs, liver, thyroid, colon, and other organs — report new or unusual symptoms immediately
Fever or signs of infection: Call your oncology team right away if your temperature is ≥100.4°F (38°C)
Platinum–Etoposide Treatment
In this video, we cover:
Why combination therapy matters: How using two drugs together can improve treatment results.
Meet the components:
Platinum (Cisplatin or Carboplatin): A chemotherapy drug that damages cancer cell DNA so the cells cannot grow or repair themselves.
Etoposide: A drug that stops cancer cells from dividing and multiplying.
Your treatment schedule: What to expect, including infusion cycles and timing.
Managing common side effects: Practical guidance on nausea, fatigue, and low blood counts — and how your care team helps you manage them.
Rituxan Treatment
This video explains everything you need to know about Rituxan treatment in a simple and clear way. We walk you through:
What Rituxan is and how it works to treat certain cancers and immune conditions
How it’s given — through an IV infusion or a subcutaneous injection called Rituxan Hycela
Treatment schedule and what to expect before, during, and after each dose
Common side effects and tips to manage them
TCHP Treatment
This video explains the TCHP treatment plan for HER2-positive breast cancer in a simple, clear way. We cover:
What TCHP is: a combination of Taxotere (docetaxel), Carboplatin, Herceptin (trastuzumab), and Perjeta (pertuzumab)
How it’s given: every 3 weeks × 6 cycles; Herceptin + Perjeta may be continued to complete 1 year of therapy
Phesgo option: Herceptin + Perjeta can also be given together as a single subcutaneous injection
Tips for managing side effects and staying safe during treatment